Ontology type: schema:ScholarlyArticle
2011-04-27
AUTHORSKlaus Sahora, Irene Kuehrer, Martin Schindl, Claus Koelblinger, Peter Goetzinger, Michael Gnant
ABSTRACTBackgroundAbout 30% of patients with pancreatic cancer suffer from locally advanced nonmetastatic carcinoma at the time of diagnosis. We conducted a prospective phase II clinical trial using neoadjuvant chemotherapy, consisting of gemcitabine and docetaxel, to assess the rate of complete radical resection and overall survival.MethodsGemcitabine (900 mg/m2) and docetaxel (35 mg/m2) were given on days 1, 8, and 15 of a 28-day cycle. Two cycles were administered for a preoperative treatment duration of 8 weeks. Patients experiencing tumor regression or stable disease and improved performance status subsequently underwent surgical exploration and pancreatic resection, if feasible. All patients were followed postoperatively to assess long-term survival.ResultsA total of 25 patients were eligible and included in the intent-to-treat and evaluable population. Thirteen patients had unresectable disease at inclusion and 12 patients had borderline resectable pancreatic cancer. Finally, 8 of 25 (32%) patients underwent resection after neoadjuvant chemotherapy; 7 (87%) of these patients had R0 resection. The median overall survival of patients who underwent resection was 16 months (95% confidence interval [CI], 8–24 months) compared to 12 months (95% CI, 8–16 months) for those without resection (p = 0.276). The median recurrence-free survival rate after resection was 12 months (95% CI, 2–21 months).ConclusionsNeoGemTax was safe and resection was feasible in a number of patients after systemic neoadjuvant treatment. Further randomized clinical trials are needed to identify novel multimodal regimens that would be able to increase the percentage of patients undergoing curative pancreatic cancer surgery despite advanced tumor stage at the time of diagnosis. More... »
PAGES1580-1589
http://scigraph.springernature.com/pub.10.1007/s00268-011-1113-8
DOIhttp://dx.doi.org/10.1007/s00268-011-1113-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1001068936
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/21523499
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adenocarcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Deoxycytidine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Docetaxel",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoadjuvant Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Staging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pancreatic Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Taxoids",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Sahora",
"givenName": "Klaus",
"id": "sg:person.01346566072.85",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346566072.85"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Kuehrer",
"givenName": "Irene",
"id": "sg:person.01312145545.83",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312145545.83"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Schindl",
"givenName": "Martin",
"id": "sg:person.0603017413.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Koelblinger",
"givenName": "Claus",
"id": "sg:person.01370076117.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370076117.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Goetzinger",
"givenName": "Peter",
"id": "sg:person.01353346274.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353346274.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",
"id": "http://www.grid.ac/institutes/grid.22937.3d",
"name": [
"Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria"
],
"type": "Organization"
},
"familyName": "Gnant",
"givenName": "Michael",
"id": "sg:person.01112754113.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112754113.07"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/978-1-4757-3656-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032089040",
"https://doi.org/10.1007/978-1-4757-3656-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11605-007-0296-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018168659",
"https://doi.org/10.1007/s11605-007-0296-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-009-0995-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021635668",
"https://doi.org/10.1007/s00280-009-0995-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1245/s10434-006-9032-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019846526",
"https://doi.org/10.1245/s10434-006-9032-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf02469407",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007111819",
"https://doi.org/10.1007/bf02469407"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6603719",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019012220",
"https://doi.org/10.1038/sj.bjc.6603719"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1245/s10434-009-0408-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051621519",
"https://doi.org/10.1245/s10434-009-0408-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1016/s1091-255x(98)80008-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015563431",
"https://doi.org/10.1016/s1091-255x(98)80008-5"
],
"type": "CreativeWork"
}
],
"datePublished": "2011-04-27",
"datePublishedReg": "2011-04-27",
"description": "BackgroundAbout 30% of patients with pancreatic cancer suffer from locally advanced nonmetastatic carcinoma at the time of diagnosis. We conducted a prospective phase II clinical trial using neoadjuvant chemotherapy, consisting of gemcitabine and docetaxel, to assess the rate of complete radical resection and overall survival.MethodsGemcitabine (900\u00a0mg/m2) and docetaxel (35\u00a0mg/m2) were given on days 1, 8, and 15 of a 28-day cycle. Two cycles were administered for a preoperative treatment duration of 8\u00a0weeks. Patients experiencing tumor regression or stable disease and improved performance status subsequently underwent surgical exploration and pancreatic resection, if feasible. All patients were followed postoperatively to assess long-term survival.ResultsA total of 25 patients were eligible and included in the intent-to-treat and evaluable population. Thirteen patients had unresectable disease at inclusion and 12 patients had borderline resectable pancreatic cancer. Finally, 8 of 25 (32%) patients underwent resection after neoadjuvant chemotherapy; 7 (87%) of these patients had R0 resection. The median overall survival of patients who underwent resection was 16\u00a0months (95% confidence interval [CI], 8\u201324\u00a0months) compared to 12\u00a0months (95% CI, 8\u201316\u00a0months) for those without resection (p\u00a0=\u00a00.276). The median recurrence-free survival rate after resection was 12\u00a0months (95% CI, 2\u201321\u00a0months).ConclusionsNeoGemTax was safe and resection was feasible in a number of patients after systemic neoadjuvant treatment. Further randomized clinical trials are needed to identify novel multimodal regimens that would be able to increase the percentage of patients undergoing curative pancreatic cancer surgery despite advanced tumor stage at the time of diagnosis.",
"genre": "article",
"id": "sg:pub.10.1007/s00268-011-1113-8",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1086446",
"issn": [
"0364-2313",
"1432-2323"
],
"name": "World Journal of Surgery",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "7",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "35"
}
],
"keywords": [
"time of diagnosis",
"pancreatic cancer",
"neoadjuvant treatment",
"neoadjuvant chemotherapy",
"overall survival",
"clinical trials",
"prospective phase II clinical trial",
"median recurrence-free survival rate",
"borderline resectable pancreatic cancer",
"recurrence-free survival rates",
"phase II clinical trial",
"improved performance status",
"resectable pancreatic cancer",
"median overall survival",
"percentage of patients",
"pancreatic cancer surgery",
"number of patients",
"advanced tumor stage",
"complete radical resection",
"II clinical trials",
"long-term survival",
"stable disease",
"evaluable population",
"unresectable disease",
"R0 resection",
"performance status",
"pancreatic resection",
"radical resection",
"surgical exploration",
"multimodal regimens",
"cancer surgery",
"tumor stage",
"tumor regression",
"nonmetastatic carcinoma",
"ResultsA total",
"resection",
"patients",
"treatment duration",
"day 1",
"survival rate",
"docetaxel",
"BackgroundAbout 30",
"cancer",
"months",
"chemotherapy",
"gemcitabine",
"survival",
"disease",
"diagnosis",
"trials",
"treatment",
"MethodsGemcitabine",
"regimens",
"surgery",
"carcinoma",
"weeks",
"total",
"duration",
"treat",
"rate",
"status",
"regression",
"population",
"percentage",
"time",
"intent",
"stage",
"cycle",
"inclusion",
"number",
"exploration"
],
"name": "NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer",
"pagination": "1580-1589",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1001068936"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00268-011-1113-8"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"21523499"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00268-011-1113-8",
"https://app.dimensions.ai/details/publication/pub.1001068936"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:27",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_538.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00268-011-1113-8"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00268-011-1113-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00268-011-1113-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00268-011-1113-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00268-011-1113-8'
This table displays all metadata directly associated to this object as RDF triples.
262 TRIPLES
22 PREDICATES
120 URIs
104 LITERALS
22 BLANK NODES